Literature DB >> 6402283

Delivery systems for intravenous nitroglycerin.

W A Mutch, I R Thomson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402283     DOI: 10.1007/BF03007727

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


× No keyword cloud information.
  7 in total

Review 1.  Intravenous nitroglycerin. A review of pharmacology, indications, therapeutic effects and complications.

Authors:  N S Hill; E M Antman; L H Green; J S Alpert
Journal:  Chest       Date:  1981-01       Impact factor: 9.410

2.  Administration set suitable for use with intravenous nitroglycerin.

Authors:  D M Baaske; A H Amann; N N Karnatz; J Wong; D M Wagenknecht; J E Carter; R G Stoll
Journal:  Am J Hosp Pharm       Date:  1982-01

3.  The loss of nitroglycerin from intravenous administration sets during infusion: a theoretical treatment.

Authors:  A H Amann; D M Baaske
Journal:  J Pharm Sci       Date:  1982-04       Impact factor: 3.534

4.  Loss of nitroglycerin from intravenous infusion sets.

Authors:  P A Cossum; A J Galbraith; M S Roberts; G W Boyd
Journal:  Lancet       Date:  1978-08-12       Impact factor: 79.321

5.  Loss of nitroglycerin from aqueous solution into plastic intravenous delivery systems.

Authors:  P H Yuen; S L Denman; T D Sokoloski; A M Burkman
Journal:  J Pharm Sci       Date:  1979-09       Impact factor: 3.534

6.  Nitroglycerin compatibility with intravenous fluid filters, containers, and administration sets.

Authors:  D M Baaske; A H Amann; D M Wagenknecht; M Mooers; J E Carter; H J Hoyt; R G Stoll
Journal:  Am J Hosp Pharm       Date:  1980-02

7.  Hemodynamic effects of intravenous nitroglycerin: importance of the delivery system.

Authors:  W A Mutch; J D Culligan; D D Cote; I R Thomson
Journal:  Anesth Analg       Date:  1982-11       Impact factor: 5.108

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.